Pfizer

Latest Stories

Nebraska could get first virus vaccine doses mid-December

By GRANT SCHULTE - Associated Press

In this Tuesday, Nov.10, 2020 file photo windows are illuminated at the headquarters of the German biotechnology company BioNTech in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world's first coronavirus shot that's backed by rigorous science — and a major step toward eventually ending the pandemic. (AP Photo/Michael Probst) **FILE**

Vaccine inventor: U.K. approval presages end of pandemic

By Tom Howell Jr. - The Washington Times

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Courtesy of University of Maryland School of Medicine via AP, File)

UK authorizes Pfizer coronavirus vaccine for emergency use

By Lauran Neergaard - Associated Press

Pfizer-BioNTech say UK allows emergency use of their COVID-19 vaccine, world’s first backed by rigor

Associated Press

CORRECTS: BioNTech and Pfizer ask European regulator for expedited approval of their COVID-19 vaccin

Associated Press

California plans for arrival of first virus vaccine doses

By AMY TAXIN - Associated Press

North Carolina Gov. Roy Cooper removes his mask before speaking during a briefing on the state's coronavirus pandemic response, Tuesday, Dec. 1, 2020 at the NC Emergency Operations Center in Raleigh, N.C. (Travis Long/The News &amp; Observer via AP)

N. Carolina to get 85,000 initial Pfizer COVID vaccine doses

By BRYAN ANDERSON - Associated Press

In this photo provided by the Michigan Office of the Governor, Michigan Gov. Gretchen Whitmer addresses the state during a speech in Lansing, Mich., Tuesday, Dec. 1, 2020. (Michigan Office of the Governor via AP)

Cautious optimism, uncertainty as state virus cases decline

By DAVID EGGERT - Associated Press

A COVID-19 test is handed through the vehicle window at a mobile testing site on Tuesday, Dec. 1, 2020, in Long Beach, Calif. (AP Photo/Ashley Landis)

Key dates as US regulators weigh emergency use of vaccines

By The Associated Press - Associated Press

FILE - In this Aug. 23, 2020, file photo Food and Drug Administration commissioner Dr. Stephen Hahn speaks during a media briefing in the James Brady Briefing Room of the White House in Washington. Hahn, the head of the agency responsible for approving any COVID-19 vaccine, was summoned to the White House Tuesday, Dec. 1, as an increasingly frustrated President Donald Trump complained that approval hasn't moved faster. (AP Photo/Alex Brandon, File)

Pushed to rush, FDA head says feds will get vaccine ‘right’

By JONATHAN LEMIRE, JILL COLVIN and MATTHEW PERRONE and ZEKE MILLER - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)

BioNTech, Pfizer ask Europe to OK vaccine for emergency use

By Frank Jordans - Associated Press

State health official updates lawmakers on vaccine latest

By SARAH RANKIN - Associated Press

A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 27, 2020. Asian stock markets declined Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism. (AP Photo/Ahn Young-joon)

Asian stocks gain on stronger Chinese factory data

By JOE McDONALD - Associated Press

FILE - In this file photo dated Wednesday, Sept. 2, 2020, University of Miami Miller School of Medicine lab technician processes blood samples from volunteers taking part in testing the NIH funded Moderna COVID-19 vaccine in Miami, USA. Britain said Sunday Nov. 29, 2020, it has secured 2 million more doses of a promising coronavirus vaccine developed by US firm Moderna, as the country aims to launch an inoculation program within days. (AP Photo/Taimy Alvarez, FILE)

UK stocks up on vaccines, hopes to start virus shots in days

By JILL LAWLESS - Associated Press

Virus news: Businesses see holiday shopping challenges

Associated Press

Debra Hearn from Penn Hills, Pa., and her sister Renee Bell, from Stanton Heights, Pa., walk to their car after a morning of shopping at Tanger Outlets in Washington, Pa., Friday, Nov. 27, 2020. The two started their traditional after Thanksgiving shopping trip at 5 a.m. (Pam Panchak/Post-Gazette via AP)

The Latest: Researchers urge Arizona shutdown, mask mandate

By The Associated Press - Associated Press

Doctors and nurses attend to a patient at the intensive care unit for COVID-19 patients in the Andras Josa hospital in Nyiregyhaza, Hungary, Thursday, Nov. 26, 2020 (Attila Balazs/MTI via AP).

The Latest: Illinois surpasses 12,000 deaths from COVID-19

By The Associated Press - Associated Press

This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (Courtesy of University of Maryland School of Medicine via AP, File)

Coronavirus vaccine priority: CDC panel to vote Tuesday

Associated Press

FILE - In this Monday, March 16, 2020 file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine. Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older. (AP Photo/Ted S. Warren, File)

CDC panel meets Tuesday to vote on COVID-19 vaccine priority

Associated Press

President Donald Trump departs behind Health and Human Services Secretary Alex Azar as Azar puts on a face mask to protect against the spread of the coronavirus after a roundtable discussion on the coronavirus outbreak and storm preparedness at Pelican Golf Club in Belleair, Fla., Friday, July 31, 2020. (AP Photo/Patrick Semansky)

Alex Azar, health secretary: Already briefing Biden team on COVID-19

By Tom Howell Jr. - The Washington Times